Norethandrolone With Maintenance Therapy Improves Survival in Elderly Patients With AML

Share this content:
Maintenance therapy with norethandrolone improves survival of elderly patients with acute myeloid leukemia without increasing toxicity.
Maintenance therapy with norethandrolone improves survival of elderly patients with acute myeloid leukemia without increasing toxicity.

Maintenance therapy with norethandrolone improves survival of elderly patients with acute myeloid leukemia (AML) without increasing toxicity, according to a study published in the Journal of Clinical Oncology.1

In a multicenter, phase 3, randomized open-label trial, French researchers examined 330 elderly patients with AML de novo or secondary to chemotherapy or radiotherapy who were randomly assigned to receive norethandrolone 10 or 20 mg per day according to body weight, or no norethandrolone for a 2-year maintenance therapy regimen.

Primary endpoint was disease-free survival by intention to treat, and secondary endpoints were event-free survival, overall survival and safety.

The researchers found that complete remission or partial remission was achieved in 247 patients (76%). Treatment with norethandrolone significantly improved survival for patients who were still in remission at 1 year after induction.

Five-year disease-free survival was 31.2% for patients receiving norethandrolone and 16.2% among those receiving only maintenance therapy, while event-free survival was 21.5% and 12.9% and overall survival was 26.3% and 17.2%, respectively.

RELATED: Age and Acute Myeloid Leukemia: A Review of Current Literature

Treatment with norethandrolone improved outcomes regardless of all prognostic factors, and only patients who had baseline leukocytes greater than 30 x 109/L saw no benefit.

Reference

  1. Pigneux A, Bene MC, Guardiola P, et al. Addition of androgens Improves survival in elderly patients with acute myeloid leukemia: A GOELAMS study. J Clin Oncol. 2016 Oct 17. doi: 10.1200/JCO.2016.67.6213 [Epub ahead of print]

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs